Precision Medicine

PARP Drugs Help Some Breast Cancer Patients, But They’re No Magic Bullet

Why All Cancer Patients Should Have Access To Genomic Testing

7 Key Cancer Trends For 2018

A New PARP Drug For Breast Cancer? I’m Thrilled!

Actually, Many New Cancer Drugs May Be Helpful And Worth Trying

A Pill Might Control Pancreatic Cancer, Even If It Doesn’t Cure It

Precision Oncology Drug Shows Power Of Cancer Genomics

In Bold Move, FDA Approves Cancer Drug For Any Advanced Tumor With Genetic Changes

Bayer’s Stivarga Shows Slim Progress Against Liver Cancer

Which Patients Will Be Helped By Immune Cancer Drugs? This Test May Tell

A PARP Inhibitor Keeps Some Cancers In Check For Years

Encouraging Results For Ribociclib In Advanced Breast Cancer

A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer

with permission, Maria Schwaederle, PharmD

The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology

Could New Lung Cancer Meds Keep Walter White From Breaking Bad?

Blood Test Offers An Amazing View Of Metastatic Prostate Cancer Cells

Five Key Issues For The Future Of Cancer IT

Companion Diagnostics? For Cancer Care, We Need Better Ones

Precision Medicine Is A Needed Goal That Will Benefit Cancer Patients

Precision Medicine Will (Eventually) Lower Cancer Care Costs

In A First, Kidney Cancer Drug Extends Survival

Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors

Thinking Ahead: From ‘The Emperor Of All Maladies’ To Precision Medicine In Cancer

Novel Drug Expands Treatment Options For Women With Metastatic Breast Cancer

For Treatment Of Polycythemia Vera, FDA Approves Jakafi, A Targeted Therapy

Perjeta Works In A Form Of Metastatic Breast Cancer: Active In Other Tumors?

The (Unmet) Potential Value of Cancer Genome Testing

With So Many Terrific New Drugs For Chronic Lymphocytic Leukemia, Why Worry?

Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer

Scientific American, April 2009

A Chip against Cancer: Microfluidics Spots Circulating Tumor Cells